Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas G Bader

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2003
Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathwayAndreas G Bader, Katherine A Felts, Ning Jiang, et al.
Cancer Research|June 24, 2010
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34Jason F Wiggins, Lynnsie Ruffino, Kevin Kelnar, et al.
Current Topics in Microbiology and Immunology|June 29, 2010
Phosphatidylinositol 3-kinase: the oncoproteinPeter K Vogt, Jonathan R Hart, Marco Gymnopoulos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 24, 2011
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in micePhong Trang, Jason F Wiggins, Christopher L Daige, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2009
Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genesFumitaka Takeshita, Lubna Patrawala, Mitsuhiko Osaki, et al.
Investigational New Drugs|December 6, 2016
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumorsMuhammad S Beg, Andrew J Brenner, Jasgit Sachdev, et al.
Cell Cycle (Georgetown, Tex.)|March 18, 2008
The let-7 microRNA reduces tumor growth in mouse models of lung cancerAurora Esquela-Kerscher, Phong Trang, Jason F Wiggins, et al.
Scientific Reports|February 25, 2025
Tuning TCR complex recruitment to the T cell antigen coupler (TAC) enhances TAC-T cell functionTrevor M Morey, Tania Benatar, Stacey X Xu, et al.
Cytotherapy|February 13, 2023
T-cell engineered with a fully humanized B-cell maturation antigen-specific T-cell antigen coupler receptor effectively target multiple myelomaKsenia Bezverbnaya, Joanne A Hammill, Derek Cummings, et al.
Molecular Therapy. Nucleic Acids|December 17, 2015
In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 RegulationMaria Angelica Cortez, David Valdecanas, Sharareh Niknam, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2003
Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathwayAndreas G Bader, Katherine A Felts, Ning Jiang, et al.
Cancer Research|June 24, 2010
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34Jason F Wiggins, Lynnsie Ruffino, Kevin Kelnar, et al.
Current Topics in Microbiology and Immunology|June 29, 2010
Phosphatidylinositol 3-kinase: the oncoproteinPeter K Vogt, Jonathan R Hart, Marco Gymnopoulos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 24, 2011
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in micePhong Trang, Jason F Wiggins, Christopher L Daige, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2009
Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genesFumitaka Takeshita, Lubna Patrawala, Mitsuhiko Osaki, et al.
Investigational New Drugs|December 6, 2016
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumorsMuhammad S Beg, Andrew J Brenner, Jasgit Sachdev, et al.
Cell Cycle (Georgetown, Tex.)|March 18, 2008
The let-7 microRNA reduces tumor growth in mouse models of lung cancerAurora Esquela-Kerscher, Phong Trang, Jason F Wiggins, et al.
Scientific Reports|February 25, 2025
Tuning TCR complex recruitment to the T cell antigen coupler (TAC) enhances TAC-T cell functionTrevor M Morey, Tania Benatar, Stacey X Xu, et al.
Cytotherapy|February 13, 2023
T-cell engineered with a fully humanized B-cell maturation antigen-specific T-cell antigen coupler receptor effectively target multiple myelomaKsenia Bezverbnaya, Joanne A Hammill, Derek Cummings, et al.
Molecular Therapy. Nucleic Acids|December 17, 2015
In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 RegulationMaria Angelica Cortez, David Valdecanas, Sharareh Niknam, et al.
Pageof 4